Equities researchers at StockNews.com started coverage on shares of OncoCyte (NYSE:OCX – Get Rating) in a research report issued on Tuesday. The firm set a “sell” rating on the stock. OncoCyte Price Performance Shares of OCX opened at $0.22 on Tuesday. OncoCyte has a 1 year low of $0.20 and a 1 year high of […]